After Fauci joined the stealth vaccine startup in 2023, the Biden administration awarded it more than $28 million to develop mRNA shots targeting viruses with pandemic potential. In 2026, Eli Lilly agreed to buy the company for up to $1.55 billion. Whether Fauci stands to profit remains intentionally hidden.
Anthony Fauci joined the scientific advisory group of a secretive mRNA vaccine company in 2023.
The following year, the Biden administration awarded the company more than $28 million to develop vaccines against viral families associated with emerging infections and potential pandemics.
Less than two years later, Eli Lilly agreed to acquire the company in a transaction worth as much as $1.55 billion to its equity holders.
A former ARPA-H program manager subsequently credited the federal agency with helping Vaccine Company land its bullion-dollar deal:
No comments:
Post a Comment